Actively Recruiting

Phase Not Applicable
Age: 65Years +
All Genders
ID07073703

Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer FRAGECO Multicenter Controlled Randomized Study

Led by Centre Hospitalier Universitaire de Saint Etienne · Updated on 2025-12-09

106

Participants Needed

2

Research Sites

26 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Bladder and kidney cancers are often diagnosed in older adults, and surgery is the main treatment for these patients. Older individuals frequently face challenges such as fatigue, reduced fitness, muscle loss, pain from disease or treatment, and poor nutrition, which increase the risk of complications and frailty after surgery. Researchers are evaluating a personalized 6-month program designed to reduce frailty in older patients undergoing surgery for bladder or kidney cancer. The study compares two groups: a control group receiving standard care, which includes assessment by an oncogeriatrician followed by surgery and rehabilitation, and an interventional group receiving standard care plus a customized program. This program involves two adapted physical activity sessions per week for four weeks before and after surgery, therapeutic education workshops addressing physical activity, nutrition, treatments, fatigue, and relaxation, and a referral to a 12-week bridge program with weekly physical activity sessions. Participants will be monitored through questionnaires and physical assessments at baseline, and at 1, 2, 3, and 6 months. Researchers will measure frailty, illness burden, physical activity levels, nutrition, memory, quality of life, fatigue, depression, muscle strength, and balance. The study includes safety follow-up and aims to evaluate patient frailty from day 1 to month 6 after surgery, with total participation lasting six months.

CONDITIONS

Brief Title

Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer.

Who Can Participate

Age: 65Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of bladder or kidney cancer
  • Scheduled for surgical treatment
  • No severe cognitive impairment preventing understanding of the protocol
  • Affiliated or entitled to a social security scheme
  • Provided informed consent to participate in the study
Not Eligible

You will not qualify if you...

  • Surgery already done
  • Significant co-morbidities contraindicating physical activity such as cardiac, respiratory, or disabling joint conditions
  • Deprived of liberty or under guardianship
  • Currently receiving prehabilitation with a private physiotherapist

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Run-in Period

Duration - 4 weeks

Participants in the interventional group attend 2 adapted physical activity (APA) sessions per week for 4 weeks before surgery.

2 sessions per week

Treatment

Duration - 6 months

Participants undergo surgery followed by a personalized 6-month care pathway including 2 APA sessions per week for 4 weeks post-surgery, therapeutic education workshops tailored to individual needs, and a 12-week bridge program with one APA session per week.

2 APA sessions per week for 4 weeks post-surgery, therapeutic education workshops as scheduled, and 1 APA session per week for 12 weeks during the bridge program

Follow-up

Duration - 6 months

Participants complete follow-up assessments including questionnaires and physical assessments at baseline, 1, 2, 3, and 6 months.

Visits at baseline, 1, 2, 3, and 6 months

Trial Site Locations

Total: 2 locations

1

Chu Saint-Etienne

Saint-Etienne, France, 42055

Actively Recruiting

2

Hôpital privé de la Loire

Saint-Etienne, France, 42100

Not Yet Recruiting

Loading map...

Research Team

E

Evolène FAYOLLE, student

A

Amandine BAUDOT, Project Manager

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Predictive Model for Recurrence and Progression Risk After...

Bladder (Urothelial, Transitional Cell) Cancer

Actively Recruiting

1 location

COBRA - Chemoablation for Low Grade Bladder Cancer: A Single...

Bladder (Urothelial, Transitional Cell) Cancer

Actively Recruiting

1 location

Bladder Microbiota and Bladder Cancer: Study of Microbial Bi...

Bladder (Urothelial, Transitional Cell) Cancer

Actively Recruiting

8 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here